XML 31 R18.htm IDEA: XBRL DOCUMENT v3.25.1
REVENUE (Notes)
 3 Months Ended
Mar. 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenue from Contract with Customer [Text Block] REVENUE
Revenue Recognition
The majority of the Company's revenue is derived from product sales. The Company's revenue related to product sales was 97 percent for the three months ended March 31, 2025 (98 percent for the three months ended March 31, 2024). The remaining sales were primarily related to the Company's insurance operations and licensing of patents and technologies. Product sales consist of sales of the Company's products to manufacturers and distributors. The Company considers order confirmations or purchase orders, which in some cases are governed by master supply agreements, to be contracts with a customer. The Company enters into licensing arrangements in which it licenses certain rights of its patents and technology to customers. Revenue from the Company’s licenses for patents and
technology is derived from sales-based royalties and licensing arrangements based on billing schedules established in each contract.

Remaining Performance Obligations
Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. At March 31, 2025, the Company had unfulfilled performance obligations of $769 million ($759 million at December 31, 2024) related to the licensing of technology. The Company expects revenue to be recognized for the remaining performance obligations over the next six years.

The Company has additional remaining performance obligations for product sales that have expected durations of one year or less, product sales of materials delivered through a pipeline for which the Company has elected the "right to invoice" practical expedient, and variable consideration attributable to royalties for licenses of patents and technology. The Company has received advance payments from customers related to long-term supply agreements that are deferred and recognized over the life of the contract, with remaining contract terms that range up to 19 years. The Company will have rights to future consideration for revenue recognized when product is delivered to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.

Disaggregation of Revenue
The Company disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See details in the tables below:

Net Trade Sales by Segment and BusinessThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Hydrocarbons & Energy$1,578 $1,467 
Packaging and Specialty Plastics3,732 3,963 
Packaging & Specialty Plastics$5,310 $5,430 
Industrial Solutions $1,054 $1,028 
Polyurethanes & Construction Chemicals1,797 1,977 
Other4 3 
Industrial Intermediates & Infrastructure$2,855 $3,008 
Coatings & Performance Monomers$845 $885 
Consumer Solutions1,226 1,267 
Performance Materials & Coatings$2,071 $2,152 
Corporate$195 $175 
Total$10,431 $10,765 

Net Trade Sales by Geographic RegionThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
U.S. & Canada$4,227 $4,130 
EMEAI 1
3,274 3,484 
Asia Pacific1,858 1,921 
Latin America1,072 1,230 
Total$10,431 $10,765 
1.Europe, Middle East, Africa and India.

Contract Assets and Liabilities
The Company receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company's contractual right to consideration for completed performance obligations not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are recognized in revenue
when the performance obligations are met. "Contract liabilities - current" primarily reflects deferred revenue from prepayments from customers for product to be delivered in 12 months or less and royalty payments that are deferred and will be recognized in 12 months or less. "Contract liabilities - noncurrent" includes advance payments that the Company has received from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract.

Revenue recognized in the first three months of 2025 from amounts included in contract liabilities at the beginning of the period was approximately $80 million (approximately $40 million in the first three months of 2024). In the first three months of 2025, the amount of contract assets reclassified to receivables as a result of the right to the transaction consideration becoming unconditional was insignificant (no contract assets reclassified to receivables in the first three months of 2024).

The following table summarizes contract assets and liabilities at March 31, 2025 and December 31, 2024:

Contract Assets and LiabilitiesBalance Sheet ClassificationMar 31, 2025Dec 31, 2024
In millions
Accounts and notes receivable - tradeAccounts and notes receivable - trade$4,917 $4,756 
Contract assets - noncurrentDeferred charges and other assets$— $2 
Contract liabilities - currentAccrued and other current liabilities$207 $244 
Contract liabilities - noncurrent Other noncurrent obligations$1,459 $1,480